Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19
Status:
Recruiting
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
This clinical trial is a randomized, blinded, two arms, placebo controlled, clinical trial to
evaluate the safety and efficacy of Mycobacterium w in combination with standard care as per
hospital practice to prevent COVID 19 in subjects at risk of getting infected with COVID 19.
Phase:
Phase 3
Details
Lead Sponsor:
Cadila Pharnmaceuticals
Collaborator:
Council of Scientific and Industrial Research, India